Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

BACKGROUND: High tumor mutation burden (TMB) has gradually become a sensitive biomarker for predicting the response to immunotherapy in many cancers, including lung, bladder and head and neck cancers. However, whether high TMB predicts the response to immunotherapy and prognosis in pancreatic ductal...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Cell Int
Autors principals: Tang, Rong, Liu, Xiaomeng, Wang, Wei, Hua, Jie, Xu, Jin, Liang, Chen, Meng, Qingcai, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Primary Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028808/
https://ncbi.nlm.nih.gov/pubmed/33827590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01900-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars